TGF-β signaling and the fibrotic response
The DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.
Abstract
The cause of fibrotic diseases, pathologies characterized by excessive production, deposition, and contraction of extracellular matrix, is unknown. To understand the molecular basis of fibrotic disease, it is essential to appreciate how matrix deposition is normally controlled and how this process is dysregulated in fibrogenesis. This review discusses the current state of knowledge concerning interactions among the profibrotic proteins transforming growth factor‐β (TGF‐β), connective tissue growth factor (CTGF, CCN2), and ED‐A fibronectin (ED‐A FN) and the antifibrotic proteins tumor necrosis factor‐α (TNF‐α) and γ‐interferon (IFN‐γ).—Leask, A., Abraham, D. J. TGF‐β signaling and the fibrotic response. FASEB J. 18, 816–827 (2004)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TGF-β is the critical mediator of pathological fibrosis after myocardial injury [64].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [64]
In the citing paper
“TNFα also suppresses the TGFβ stimulation of ECM production.62”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [62]
Citations
Cites
1 retracted
RETRACTED: Deficient Smad7 expression: A putative molecular defect in scleroderma
Dong, C., Zhu, S., Wang, T., Yoon, W., Li, Z., Alvarez, R. J., ten Dijke, P., White, B., Wigley, F. M., & Goldschmidt-Clermont, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062010399 · Cited by 244 · cited 1×
“Although one report showed decreased levels of the inhibitory Smad7 in scleroderma fibroblasts (94), two other studies showed no difference in Smad7 levels between normal and scleroderma fibroblasts (65, 91); thus, Smad7 deficiency does not seem to be a general feature of scleroderma fibroblasts.”
ResultRetractedMassagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556 · cited 4×
“The TGF- superfamily includes nearly 30 proteins in mammals including TGF- s, activins and inhibins, nodal, myostatin, bone morphogenetic proteins (BMPs), growth/differentiation factors (GDFs), and anti-Müllerian hormone (AMH, also called Müllerianinhibiting substance or MIS) (15, 16).”
BackgroundInfluentialDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 2×
“Transcriptional responses induced by IFN- in most cells are mediated through the Jak-Stat pathway (146).”
BackgroundCELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · cited 1×
“IFN- , a pleiotropic cytokine produced by T cells and NK cells, plays fundamental roles in innate and acquired immune responses (145).”
BackgroundYu, Q., & Stamenkovic, I. (2000) · PubMed Central · Cited by 2,203
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076 · cited 1×
“TSP-1 null mice demonstrate a partial phenotypic overlap with TGF- 1 null animals (30), and integrin 6 / are highly resistant to lung fibrosis induced by the profibrotic drug bleomycin (31).”
BackgroundIdentification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754 · cited 1×
“For example, the plasmin proteases MMP-2 and -9, which promote matrix degradation (24), activate TGF- (25, 26).”
BackgroundThe myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630 · cited 5×
“observed in lesions of fibrotic disease (2).”
BackgroundInfluentialMaking sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Research works printed but not linked: 3
- 10.1111/j.1523-1755.2002.kid567.x · doi:10.1111/j.1523-1755.2002.kid567.x · Paper page
- Schmid P., 1998, Enhanced expression oftransforming growth factor-beta type and type II receptors in wound granulation tissue and hyper trophic scar, Am. J. Pathol., 152, 485
- 10.1111/j.1523-1755.1998.00820.x · doi:10.1111/j.1523-1755.1998.00820.x · Paper page
Cited by
Items 601–700 of 1,008
TGFβ/Smad4-Dependent and -Independent Regulation of Human Lens Epithelial Cells
Dawes, L. J., Sleeman, M. A., Anderson, I. K., Reddan, J. R., & Wormstone, I. M. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3223 · Cited by 63
Nawroth, I., Alsner, J., Behlke, M. A., Besenbacher, F., Overgaard, J., Howard, K. A., & Kjems, J. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.09.010 · Cited by 63
“The role of TNFa, however, in the fibrotic process remains contentious [1,14,19].”
BackgroundChen, Q., Lee, C. E., Denard, B. S., & Ye, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108528 · Cited by 63
“Yet the collagenstimulating effects of TGF-b persist for days [6,10].”
BackgroundSapudom, J., Rubner, S., Martin, S., Stephan, T., Anderegg, U., & Pompe, W. (2015) · Biomaterials Science · doi:10.1039/c5bm00140d · Cited by 64
Notch2 negatively regulates myofibroblastic differentiation of myoblasts
Ono, Y., Sensui, H., Okutsu, S., & Nagatomi, R. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20838 · Cited by 63
“…pathologic fibrosis in various tissues including skeletal Journal of Cellular Physiology DOI 10.1002/jcp muscle (Yamazaki et al., 1994; Bernasconi et al., 1995, 1999; Davison et al., 1999; Powell et al., 1999; Ishitobi et al., 2000; Li and Huard, 2002; Leask and Abraham, 2004; Li et al., 2004).”
BackgroundInfluentialFineschi, S., Reith, W., Guerne, P. A., Dayer, J., & Chizzolini, C. (2006) · The FASEB Journal · doi:10.1096/fj.05-4870fje · Cited by 63
“Recent data have shown that of the MAP kinases, p38 and ERK favor ECM deposition, whereas JNK is generally considered to be antifibrotic (14).”
BackgroundBayhan, Z., Zeren, S., Koçak, F. E., Koçak, C., Akçılar, R., Karğı, E., Tiryaki, Ç., Yaylak, F., & Akçılar, A. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.11.033 · Cited by 64
Khan, S. A., Dong, H., Joyce, J., Sasaki, T., Chu, M., & Tsuda, T. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.52 · Cited by 63
MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis
Mizuno, K., Mataki, H., Seki, N., Kumamoto, T., Kamikawaji, K., & Inoue, H. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.98 · Cited by 64
Li, H., Yang, L., Zhang, Y., & Gao, Z. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.011 · Cited by 67
Ubiquitin-Dependent Regulation of TGβ Signaling in Cancer
Izzi, L., & Attisano, L. (2006) · Neoplasia · doi:10.1593/neo.06472 · Cited by 70
Endothelial-to-Mesenchymal Transition in Cardiovascular Pathophysiology
Singh, A. D., Bhatt, K. S., Nguyen, H. C., Frisbee, J. C., & Singh, K. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116180 · Cited by 66
“Phosphorylated Smad2 and Smad3 form complexes with Smad4, which then translocate into the nucleus and regulate the transcription of target genes associated with EndMT, such as Snai1, Snai2, and Twist1 (Figure 3) [30,31].”
BackgroundDuan, L. J., Qi, J., Kong, X., Huang, T., Qian, X. Q., Xu, D., Liang, J., & Kang, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.11.001 · Cited by 62
Autoimmune Pancreatitis: Expression and Cellular Source of Profibrotic Cytokines and Their Receptors
Detlefsen, S., Sipos, B., Zhao, J., Drewes, A. M., & Klöppel, G. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31815d2583 · Cited by 64
Modulation of cutaneous wound healing by ozone: Differences between young and aged mice
Lim, Y., Phung, A. D., Corbacho, A. M., Aung, H. H., Maioli, E., Reznick, A. Z., Cross, C. E., Davis, P. A., & Valacchi, G. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.06.013 · Cited by 66
Targeting latent TGFβ release in muscular dystrophy
Ceco, E., Bogdanovich, S., Gardner, B. B., Miller, T. A., DeJesus, A., Earley, J. U., Hadhazy, M., Smith, L., Barton, E. R., Molkentin, J. D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3010018 · Cited by 62
“TGFb activity is triggered in both chronic and acute muscle injury (10, 15).”
BackgroundWang, J., Jiao, H., Stewart, T. L., Lyons, M. V. H., Shankowsky, H. A., Scott, P. G., & Tredget, E. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/0507306 · Cited by 62
The role of circulating fibrocytes in inflammation and autoimmunity
Galligan, C. L., & Fish, E. N. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0712365 · Cited by 68
Effect of ginseng extract on the TGF-β1 signaling pathway in CCl4-induced liver fibrosis in rats
Hafez, M. M., Hamed, S. S., El‐Khadragy, M. F., Hassan, Z. K., Al-Rejaie, S. S., Sayed‐Ahmed, M. M., Al-Harbi, N. O., Al-Hosaini, K. A., Al-Harbi, M. M., Alhoshani, A., et al. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1507-0 · Cited by 77
Hermenean, A. O., Mariasiu, T., NAVARRO-GONZÁLEZ, I., Vegara-Meseguer, J. M., Miuţescu, E., Chakraborty, S., & Pérez‐Sánchez, H. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4181 · Cited by 68
Dual surface modification of PDMS-based silicone implants to suppress capsular contracture
Yoo, B. Y., Kim, B. H., Lee, J. S., Shin, B. H., Kwon, H., Koh, W., & Heo, C. Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.06.022 · Cited by 64
Arnott, J. A., Nuglozeh, E., Rico, M. C., Arango‐Hisijara, I., Odgren, P. R., Safadi, F. F., & Popoff, S. N. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20917 · Cited by 62
“The recent identification of CTGF as an essential downstream effector of TGF-b1 in certain biological and pathological processes (Gore-Hyer et al., 2002; Yokoi et al., 2002; Weston et al., 2003; Leask and Abraham, 2004) has sparked interest in this novel mechanism of action.”
BackgroundInterleukin-1 beta regulates proximal tubular cell transforming growth factor beta-1 signalling
Luo, D. D., Fielding, C., Phillips, A., & Fraser, D. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp208 · Cited by 62
Chapman, M., Zhang, J., Banerjee, I., Guo, L. T., Zhang, Z., Shelton, G. D., Ouyang, K., Lieber, R. L., & Chen, J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu310 · Cited by 67
Common pathway signature in lung and liver fibrosis
Makarev, E., Izumchenko, E., Aihara, F., Wysocki, P., Zhu, Q., Buzdin, A. A., Sidransky, D., Zhavoronkov, A. A., & Atala, A. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1152435 · Cited by 69
Lambers, C., Roth, M., Jaksch, P., Muraközy, G., Tamm, M., Klepetko, W., Ghanim, B., & Zhao, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-19294-1 · Cited by 61
Zimman, O. A., Toblli, J. E., Stella, I., Ferder, M., Ferder, L., & Inserra, F. (2007) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000287381.93729.e2 · Cited by 67
Goulet, S., Bihl, M., Gambazzi, F., Tamm, M., & Roth, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20836 · Cited by 61
“TGF-b1 contributes to the daily and pathological ECM turnover in the lung and also modulates cell proliferation, differentiation, migration, and apoptosis (Bartram and Speer, 2004; Leask and Abraham, 2004).”
BackgroundPark, K., Hong, S. W., Hur, W., Lee, M. Y., Yang, J., Kim, S. W., Yoon, S. K., & Hahn, S. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.044 · Cited by 61
Ghatak, S., Misra, S., Norris, R. A., Moreno‐Rodriguez, R. A., Hoffman, S., Levine, R. A., Hascall, V. C., & Markwald, R. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.539882 · Cited by 61
Regulation of pro‐inflammatory and pro‐fibrotic factors by CCN2/CTGF in H9c2 cardiomyocytes
Wang, X., McLennan, S. V., Allen, T. J., & Twigg, S. M. (2010) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0083-1 · Cited by 65
“Also known as CCN2, the protein CTGF is considered to be a mediator involved in fibrotic processes (Leask and Abraham 2004) and it stimulates fibroblast growth and ECM protein up-regulation in vitro and in vivo.”
BackgroundPathophysiology and Management of the Burn Scar
Ladak, A., & Tredget, E. E. (2009) · Clinics in Plastic Surgery · doi:10.1016/j.cps.2009.05.014 · Cited by 71
Primary sclerosing cholangitis: a review and update on therapeutic developments
Tabibian, J. H., & Lindor, K. D. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.80 · Cited by 61
Seo, G., Lim, Y., Koh, D., Huh, J., Hyun, C. L., Kim, Y., & Cho, M. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.167 · Cited by 64
Xue, J., Xiao, T., Wei, S., Sun, J., Zou, Z., Shi, M., Sun, Q., Dai, X., Wu, L. Y., Li, J., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30288 · Cited by 64
Pabic, H. L., L’Helgoualc’h, A., Coutant, A., Wewer, U. M., Baffet, G., Clément, B., & Théret, N. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.025 · Cited by 61
“dependent pathway has been involved in the initiation of fibrotic response, growing evidences suggest that the maintenance of the fibrotic phenotype does not require Smad [21].”
BackgroundType I Collagen Structure, Synthesis, and Regulation
Bou–Gharios, G., & Crombrugghe, B. D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00034-3 · Cited by 75
Cooker, L. A., Peterson, D., Rambow, J., Riser, M. L., Riser, R. E., Najmabadi, F., Brigstock, D., & Riser, B. L. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00508.2006 · Cited by 60
Formation of vitamin A lipid droplets in pancreatic stellate cells requires albumin
Kim, N., Yoo, W., Lee, J., Kim, H., Lee, H. S., Kim, Y.-S., Kim, D.-U., & Oh, J. (2009) · Gut · doi:10.1136/gut.2008.170233 · Cited by 61
Transforming Growth Factor-β Signaling Pathway Activation in Keratoconus
Engler, C., Chakravarti, S., Doyle, J. J., Eberhart, C. G., Meng, H., Stark, W. J., Kelliher, C., & Jun, A. S. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.11.008 · Cited by 67
Aihara, K.-I., Ikeda, Y., Yagi, S., Akaike, M., & Matsumoto, T. (2011) · Cardiology Research and Practice · doi:10.4061/2011/175381 · Cited by 58
“In addition, it has been reported that TGF-β1 reduces collagenase production and accelerates the expression of tissue inhibitors of MMPs, resulting in overall inhibition of ECM degradation and leading to excessive matrix accumulation [6, 30].”
BackgroundKruse, J. J. C. M., Floot, B. G. J., Poele, J. A. M. T., Russell, N. S., & Stewart, F. A. (2009) · Radiation Research · doi:10.1667/rr1526.1 · Cited by 60
Ezzoukhry, Z., Henriet, E., Piquet, L., Boyé, K., Bioulac‐Sage, P., Balabaud, C. P., Couchy, G., Zucman‐Rossi, J., Moreau, V., & Saltel, F. (2016) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2016.09.003 · Cited by 63
Kim, C.-R., Kim, Y.-M., Lee, M.-K., Kim, I.-H., Choi, Y.-H., & Nam, T.-J. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2807 · Cited by 59
“The process is also related to the TGF-β /Smad signaling pathway (32).”
Zhang, Y., Liang, R., Chen, C.-W., Mallano, T., Dees, C., Distler, A., Reich, A., Bergmann, C., Ramming, A., Gelse, K., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210911 · Cited by 64
Liu, Y., Gao, L., Zhao, X., Guo, S., Liu, Y., Li, R., Liang, C., Li, L., Dong, J., Li, L., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27022 · Cited by 61
Rodius, S., de Klein, N., Jeanty, C., Sánchez-Iranzo, H., Crespo, I., Ibberson, M. R., Xénarios, I., Dittmar, G., Mercader, N., Niclou, S. P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-59894-4 · Cited by 60
The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts
Chen, S., McLean, S., Carter, D. E., & Leask, A. (2007) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-007-0015-x · Cited by 58
“However, Wnt 3a did not cause an as potent induction of other profibrotic/ matrix remodeling genes as, say, application of TGFβ or ET-1 to fibroblasts (Shi-wen et al. 2004, Liu et al. 2007; Leask and Abraham 2004).”
BackgroundSelf-citationZizyphus spina-christi protects against carbon tetrachloride-induced liver fibrosis in rats
Amin, A., & Mahmoud‐Ghoneim, D. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.05.038 · Cited by 64
Disruption of the Smad7 gene enhances CCI4‐dependent liver damage and fibrogenesis in mice
Hamzavi, J., Ehnert, S., Godoy, P., Ciuclan, L. I., Weng, H., Mertens, P. R., Heuchel, R. L., & Dooley, S. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00262.x · Cited by 60
“In contrast to quiescent HSCs, activated myofibroblasts lack TGF- dependent induction of Smad7 in vitro and in vivo, and thus may contribute to chronic TGF- signalling and fibrogenesis [5–42].”
BackgroundFibroblasts: Diverse Cells Critical to Biomaterials Integration
Hannan, R. T., Peirce, S. M., & Barker, T. H. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00244 · Cited by 59
Varricchio, L., Iancu‐Rubin, C., Upadhyaya, B., Zingariello, M., Martelli, F., Verachi, P., Clementelli, C., Denis, J.-F., Rahman, A. H., Tremblay, G., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.145651 · Cited by 61
Bish, L. T., Yarchoan, M. M., Sleeper, M. M., Gazzara, J. A., Morine, K., Acosta, P., Barton, E. R., & Sweeney, H. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020856 · Cited by 61
“DMD leads to fibrosis, a process that is mediated largely by transforming growth factor beta (TGF-b) [4,5].”
BackgroundTu, C., Li, J., Wang, F.-P., Li, L., Wang, J., & Jiang, W. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.08.013 · Cited by 64
“interleukin (IL)-10, interferon (IFN)-γ [3–7].”
BackgroundInfluentialDesmosomes in the Heart: A Review of Clinical and Mechanistic Analyses
Patel, D. M., & Green, K. J. (2014) · Cell Communication & Adhesion · doi:10.3109/15419061.2014.906533 · Cited by 65
“TGF- β 3 is a key regulator of fi brotic signaling pathways (Leask & Abraham, 2004; Varga & Jimenez, 1986); thus, these mutations could induce fi brosis by stimulating proliferation of mesenchymal cells.”
BackgroundHayashida, K., Johnston, D. R., Goldberger, O., & Park, P. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509320200 · Cited by 59
Ito, Y., Goldschmeding, R., Kasuga, H., Claessen, N., Nakayama, M., Yuzawa, Y., Sawai, A., Matsuo, S., Weening, J. J., & Aten, J. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00120.2009 · Cited by 72
Kelly, D. J., Zhang, Y., Connelly, K. A., Cox, A. J., Martin, J. H., Krum, H., & Gilbert, R. E. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01167.2006 · Cited by 60
The Fibrotic Response to Implanted Biomaterials: Implications for Tissue Engineering
Rolfe, B. E., Mooney, J. E., Zhang, B., Jahnke, S., Le, S.-J., Chau, Y.-Q., Huang, Q., Wang, H., CAMPBELL, G. R., & Campbell, J. (2011) · InTech eBooks · doi:10.5772/21790 · Cited by 68
“TGF-β is the principal mediator of myofibroblast differentiation in wound healing, inducing fibroblasts (and possibly other cell types) to differentiate into α-SM actin-expressing myofibroblasts with the capacity for contraction and ECM synthesis (Leask & Abraham, 2004).”
BackgroundBao, Q., Zhang, B., Suo, Y., Liu, C., Yang, Q., Zhang, K., Yuan, M., Yuan, M., Zhang, Y., & Li, G. (2020) · eLife · doi:10.7554/elife.49923 · Cited by 63
“…perhaps the most extensively studied mediator of fibroblast activation and having the greatest role in pathological fibrosis (Travers et al., 2016; Leask and Abraham, 2004), can be activated by TSP1 binding to a defined site on latency-associated propeptide and inducing a conformational change in…”
BackgroundRelevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases.
Zvaifler, N. J. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1963 · Cited by 75
“Fibroblasts, fibrosis and systemic sclerosis Until recently, scleroderma research focused mainly on the unique nature of the systemic sclerosis (SSc) fibroblast, its ability to produce ECM molecules, especially collagens, and the responsible growth factors, especially TGF-β [47-49].”
BackgroundFoam Cell Formation In Vivo Converts Macrophages to a Pro-Fibrotic Phenotype
Thomas, A. C., Eijgelaar, W. J., Daemen, M. J. A. P., & Newby, A. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128163 · Cited by 62
“CTGFmay act synergistically with TGFβ [28,56] and can promote monocyte migration into the atherosclerotic plaque [58].”
BackgroundInfluentialRegional variation in arterial stiffening and dysfunction in Western diet-induced obesity
Bender, S. B., Castorena‐Gonzalez, J. A., Garro, M., Reyes‐Aldasoro, C. C., Sowers, J. R., DeMarco, V. G., & Martinez‐Lemus, L. A. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00155.2015 · Cited by 61
“Elastin and collagen production and stiffening of extracellular matrices have been associated with increased TGFsignaling (15, 25, 27).”
BackgroundKwan, P. O., Ding, J., & Tredget, E. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123054 · Cited by 60
“TGF-β1 Upregulates miR-181b Expression in Dermal Fibroblasts but CTGF does not Since TGF-β1 is a key profibrotic cytokine in HSc development [44], its effects on miR-24 and miR-181b in SF and DF were examined using RT-qPCR.”
MethodBurgess, J. K. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.12.002 · Cited by 67
Towards a unified approach in the modeling of fibrosis: A review with research perspectives
Amar, M. B., & Bianca, C. (2016) · Physics of Life Reviews · doi:10.1016/j.plrev.2016.03.005 · Cited by 63
Antioxidant therapy against TGF ‐β/ SMAD pathway involved in organ fibrosis
Ghafouri‐Fard, S., Askari, A., Shoorei, H., Seify, M., Koohestanidehaghi, Y., Hussen, B. M., Taheri, M. N., & Samsami, M. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18052 · Cited by 62
Fibroblast Function and Wound Breaking Strength Is Impaired by Acute Ethanol Intoxication
Ranzer, M. J., Chen, L., & DiPietro, L. A. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01324.x · Cited by 57
“…to this process can occur as a result of changes in signaling events, pathologic conditions, or exogenous factors (Branton and Kopp, 1999; Kovacs and DiPietro, 1994; Leask and Abraham, 2004; Radek et al., 2007; Steffensen et al., 2001; Uchiyama et al., 2000; Yamaguchi and Yoshikawa, 2001).”
BackgroundAltered TGF ‐β signaling in fetal fibroblasts: What is known about the underlying mechanisms?
Walraven, M., Gouverneur, M., Middelkoop, E., Beelen, R. H. J., & Ulrich, M. M. W. (2013) · Wound Repair and Regeneration · doi:10.1111/wrr.12098 · Cited by 65
“The exact function of this receptor is not completely understood, but it has been shown to promote binding of the TGF-β isoforms, especially TGF-β2, to the TGF-βRII, thereby enhancing the TGF-β response.(1,54,62,63) Furthermore, overexpression of this receptor in certain cell cultures has been shown to affect receptor…”
BackgroundMurakami, K., Kohno, M., Kadoya, M., Nagahara, H., Fujii, W., Seno, T., Yamamoto, A., Oda, R., Fujiwara, H., Kubo, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106792 · Cited by 59
“It induces the transformation of fibroblasts into myofibroblasts, which are able to secrete TGF-b and stimulate extracellular matrix (ECM) deposition [24,25].”
BackgroundActions of IGF binding proteins and related proteins in adipose tissue
Baxter, R. C., & Twigg, S. M. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.07.002 · Cited by 57
Soumyakrishnan, S., Divya, T., Kalayarasan, S., Narayanan, S., & Sudhandiran, G. (2014) · Biochimie · doi:10.1016/j.biochi.2014.04.005 · Cited by 58
Fan, Y., Fang, X., Tajima, A., Geng, X., Ranganathan, S., Dong, H. H., Trucco, M., & Sperling, M. A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00218 · Cited by 60
Cieslik, K. A., Trial, J., Crawford, J. R., Taffet, G. E., & Entman, M. L. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.10.017 · Cited by 60
“Although TGF-β seems to be essential for development of fibrosis via induction of ECM protein synthesis [67] and promotion of fibroblast maturation [68] its role in aging dependent fibrosis may be different and related to signal alteration via downregulation of the receptor [58] or switch of preferential effector down…”
BackgroundDiagnosis and Therapy of Localized Scleroderma
Kreuter, A., Krieg, T. M., Worm, M., Wenzel, J., Gambichler, T., Kuhn, A., Aberer, E., Scharffetter‐Kochanek, K., & Hunzelmann, N. (2009) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2009.07178.x · Cited by 57
Kuiper, E. J., van Zijderveld, R., Roestenberg, P., Lyons, K. M., Goldschmeding, R., Klaassen, I., Noorden, C. J. F. V., & Schlingemann, R. O. (2008) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2008.950980 · Cited by 58
“However, inhibition of TGF-b to prevent BL thickening, thereby ameliorating early retinal vascular changes caused by diabetes, may have severe adverse effects because of its important physiological functions in tumor suppression and dampening of inflammation (Leask and Abraham 2004).”
BackgroundTAF4 inactivation in embryonic fibroblasts activates TGFβ signalling and autocrine growth
Mengus, G., Fadloun, A., Kobi, D., Thibault-Carpentier, C., Perletti, L., Michel, I., & Davidson, I. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600748 · Cited by 66
“CTGF has intrinsic growth factor properties and acts as a secondary mediator of the proliferative response of fibroblasts to TGFb, in particular during the development of fibrosis (Leask and Abraham, 2004).”
BackgroundInfluentialGuo, H., Bazuine, M., Jin, D., Huang, M. M., Cushman, S. W., & Chen, X. (2013) · Endocrinology · doi:10.1210/en.2013-1289 · Cited by 53
Expression and regulation of cathepsin K in skin fibroblasts
Quintanilla‐Dieck, M. J., Codriansky, K. A., Keady, M., Bhawan, J., & Rünger, T. M. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00855.x · Cited by 57
Jia, H., François, F., Bourien, J., Eybalin, M., Lloyd, R. V., Water, T. R. V. D., Puel, J., & Venail, F. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.031 · Cited by 60
Lucarini, L., Durante, M., Lanzi, C., Pini, A., Boccalini, G., Calosi, L., Moroni, F., Masini, E., & Mannaioni, G. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12967 · Cited by 57
Pathogenesis of non-alcoholic fatty liver disease mediated by YAP
Chen, P., Luo, Q., Huang, C., Gao, Q., Li, L., Chen, J., Chen, B., Liu, W., Zeng, W., & Chen, Z. (2018) · Hepatology International · doi:10.1007/s12072-017-9841-y · Cited by 62
Robinson, N. A., Pleasance, J., Piedrafita, D. M., & Meeusen, E. N. T. (2010) · International Journal for Parasitology · doi:10.1016/j.ijpara.2010.11.006 · Cited by 57
Akool, E., Doller, A., Müller, R., Gutwein, P., Xin, C., Huwiler, A., Pfeilschifter, J. M., & Eberhardt, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504140200 · Cited by 57
Zhang, A., Liu, X., Cogan, J. G., Fuerst, M. D., Polikandriotis, J. A., Kelm, R. J., & Strauch, A. R. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-03-0216 · Cited by 76
Identification of Endoglin in Rat Hepatic Stellate Cells
Meurer, S. K., Tihaa, L., Lahme, B., Gressner, A. M., & Weiskirchen, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405411200 · Cited by 57
Gupta, D. K., Singh, N., & Sahu, D. K. (2014) · Cancer Growth and Metastasis · doi:10.4137/cgm.s14205 · Cited by 59
The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model
Balistreri, E., Garcia-Gonzalez, E., Selvi, E., Akhmetshina, A., Palumbo, K., Lorenzini, S., Maggio, R., Lucattelli, M., Galeazzi, M., & Distler, J. W. H. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137539 · Cited by 56
Selige, J., Hatzelmann, A., & Dunkern, T. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22529 · Cited by 56
“Therefore, the TGF-b-induced myofibroblast conversion is expected to have a key role in perpetuating inflammation, deposition of connective tissue, thus affecting lung functions (Leask and Abraham, 2004).”
BackgroundLin, Y., Li, Y., Chen, P., Zhang, Y., Sun, J., Sun, X., Li, J., Jin, J., Xue, J., Zheng, J., et al. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad007 · Cited by 58
Mathematical model of renal interstitial fibrosis
Hao, W., Rovin, B. H., & Friedman, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413970111 · Cited by 56
Fisher, P. W., Zhao, Y., Rico, M. C., Massicotte, V. S., Wade, C. K., Litvin, J., Bove, G. M., Popoff, S. N., & Barbe, M. F. (2015) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-015-0263-0 · Cited by 63
Chen, N., Geng, Q., Zheng, J., He, S., Huo, X., & Sun, X. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1867 · Cited by 61
Yin Yang 1 Is a Novel Regulator of Pulmonary Fibrosis
Lin, X., Sime, P. J., Xu, H., Williams, M. A., LaRussa, L., Georas, S. N., & Guo, J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0232oc · Cited by 57
Experimental inhibition of porcupine-mediated Wnt O-acylation attenuates kidney fibrosis
Madan, B., Patel, M. B., Zhang, J., Bunte, R. M., Rudemiller, N. P., Griffiths, R., Virshup, D. M., & Crowley, S. D. (2016) · Kidney International · doi:10.1016/j.kint.2016.01.017 · Cited by 58
Zhao, J., Shu, B., Chen, L., Tang, J., Zhang, L., Xie, J., Liu, X., Xu, Y., & Qi, S. (2016) · Experimental Dermatology · doi:10.1111/exd.13014 · Cited by 64
Adverse outcome pathway development from protein alkylation to liver fibrosis
Horvat, T., Landesmann, B., Lostia, A., Vinken, M., Munn, S., & Whelan, M. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1814-8 · Cited by 53
“TGF-β1 further recruits inflammatory cells, portal fibroblasts, and circulating myofibroblasts to the injured liver and triggers the apoptosis of hepatocytes (Kershenobich Stalnikowitz and Weissbrod 2003; Leask and Abraham 2004; Parsons et al. 2007; Williams et al. 2000).”
BackgroundChanda, D., Kurundkar, A., Rangarajan, S., Locy, M. L., Bernard, K. F., Sharma, N., Logsdon, N. J., Liu, H., Crossman, D. K., Horowitz, J. C., et al. (2016) · Scientific Reports · doi:10.1038/srep37445 · Cited by 60
Oscarsson, N., Ny, L., Mölne, J., Lind, F., Ricksten, S., Seeman-Lodding, H., & Giglio, D. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.036 · Cited by 56
Anti‐fibrotic mechanisms of angiotensin AT2‐receptor stimulation
Sumners, C., Peluso, A. A., Haugaard, A. H., Bertelsen, J. B., & Steckelings, U. M. (2019) · Acta Physiologica · doi:10.1111/apha.13280 · Cited by 55
Metadata
- Authors
- Leask, A., & Abraham, D. J.
- Affiliations
- The Royal Free Hospital (GB)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 18
- Issue
- 7
- Pages
- 816-827
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2122808924
- Cited by
- 2,319
- References
- 153
- Citations by year
- 2026: 53 · 2025: 53 · 2024: 63 · 2023: 79 · 2022: 75 · 2021: 103 · 2020: 99 · 2019: 113 · 2018: 145 · 2017: 174 · 2016: 163 · 2015: 179 · 2014: 141 · 2013: 134 · 2012: 115
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Scleroderma Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- TGF-beta signaling, fibrosis, fibrogenesis, extracellular matrix deposition, connective tissue growth factor, ED-A fibronectin, TNF-α, interferon-gamma
- MeSH terms
- Animals, DNA-Binding Proteins, Fibronectins, Fibrosis, Gene Expression Regulation, Humans, Interferon-gamma, Tumor Necrosis Factor-alpha, Wound Healing, Signal Transduction, Trans-Activators, Transforming Growth Factor beta, Extracellular Matrix Proteins, Immediate-Early Proteins, Receptors, Transforming Growth Factor beta, MAP Kinase Signaling System, Intercellular Signaling Peptides and Proteins, Smad3 Protein, Smad4 Protein, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.